Pathology and genetics: Tumours of haematopoietic and lymphoid tissues
By P. Vyas. 2001
813 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/0d4ebc13060f91efe6f7db38e83354d035427aed
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- C. DeSantis
- A. Jemal
- H. Döhner
- R. Schlenk
- L. Teras
- L. Bullinger
- P. Paschka
- J. Flores-Montero
Citations in the corpus
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes (2016, methodology): “The WHO classification system is currently considered the “gold standard” for classifying all hematopoietic neoplasms.(15) That classification scheme takes into account many aspects of the disease, including morphology, immunophenotype, and cytogenetic and molecular characteristics.”
- TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. (2012, methodology): “The diagnosis of AML was based on French-American-British Cooperative Group criteria(18), and after 2004 on WHO criteria(19).”
- The 2008 WHO classification of lymphomas: implications for clinical practice and translational research (2009, unknown): “The 2008 WHO classification eliminated the variant category of “atypical BL,” which had been included in the 2001 classification.(45) Thus, a case with the typical BL phenotype (CD20, BCL6, CD10, BCL2) and genotype (so-called MYC-simple or MYC/IG in the absence of other major cytogenetic anomalies) ”
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes (2012, background): “In previous versions of the WHO classification (284) only the percentage of cells expressing a marker was taken into account, whereas in the more recent 2008 version (3) the intensity of antigen expression is now also regarded to be important.”